Optogenetic fMRI Brain Dynamics Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for modeling brain dynamics in normal and diseased states are limited by their inability to precisely capture brain network function dynamics, making it challenging to design and evaluate therapeutic options effectively.
Innovation Solution
The development of a methodology using optogenetic stimulation and functional magnetic resonance imaging (fMRI) to create precise models of brain dynamics, allowing for the longitudinal probing of brain function and the design of targeted therapeutics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional animal models are used to study neurological diseases, then the models can be generated using mechanical injury, drug delivery, electrical stimulation, and genetic alterations, but the ability to precisely capture brain network function dynamics is limited
Solution Approach 1:
The patent segments the brain into distinct cell-type specific networks and models each separately using optogenetic labeling. This allows precise tracking of function dynamics in specific neuronal populations (e.g., pyramidal neurons vs. interneurons) while maintaining overall system integration, thereby achieving high measurement precision without overwhelming complexity.
Solution Approach 2:
The patent employs optogenetic stimulation to dynamically change neural activity parameters (firing rates, synchronization patterns) in real-time during fMRI scanning. This enables precise capture of brain network function dynamics by manipulating and measuring multiple parameters simultaneously, resolving the contradiction between precision and complexity.
2Manufacturing precision
If optogenetic stimulation and fMRI are used to create precise models of brain dynamics, then cell-type specific brain function can be categorized precisely, but the device complexity and methodology sophistication increase
Solution Approach 1:
The patent uses optogenetic proteins (Channelrhodopsin-2, Halorhodopsin) as intermediaries to translate light signals into specific neuronal activation or inhibition patterns. This intermediary mechanism enables precise control of neuronal populations during fMRI scanning, achieving high model precision while managing system complexity through well-characterized molecular tools.
Solution Approach 2:
The patent replaces conventional mechanical injury models and electrical stimulation methods with optogenetic light-based control. This substitution provides superior precision in targeting specific cell types while reducing off-target effects, thereby improving model precision without proportionally increasing overall system complexity.
3Reliability
If longitudinal probing of brain function is implemented to evaluate therapeutic efficacy, then therapeutic options can be evaluated effectively, but the time and resource requirements increase
Solution Approach 1:
The patent implements continuous longitudinal monitoring of brain network dynamics using repeated optogenetic-fMRI sessions and EEG recordings over time. This continuous measurement approach enables reliable evaluation of therapeutic effects while minimizing gaps in data collection, thereby improving reliability without excessive time loss.
Solution Approach 2:
The patent incorporates real-time feedback loops where EEG and fMRI data are continuously analyzed to adjust stimulation parameters and therapeutic interventions. This feedback mechanism accelerates therapeutic evaluation by dynamically optimizing measurement conditions, improving reliability while reducing overall study duration through efficient adaptive design.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the precise categorization of neurological disorders based on cell-type specific brain function, allowing for the evaluation of therapeutic efficacy and the active design of treatments to alter diseased brain function.
Implementation Method 1
Optogenetic stimulation and functional magnetic resonance imaging readout may be used to idenfity ways to create animal models with precise origin and corresponding brain network dynamics
Implementation Method 2
functional magnetic resonance imaging (fMRI) imaging
Implementation Method 3
making further measurements to interpret electroencephalography (EEG) measurement based on the categorizing during light responsive stimulation
Data Source
Figure 1a~1b
Figure 2a~2b
Figure 3a~3b
AI summary
A system and method is provided for modeling brain dynamics in normal and diseased states.